These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 12132415)

  • 1. PET scan detects recurrent breast cancer.
    Health News; 2002 May; 8(5):9. PubMed ID: 12132415
    [No Abstract]   [Full Text] [Related]  

  • 2. Oncological applications of FDG PET imaging.
    Delbeke D
    J Nucl Med; 1999 Oct; 40(10):1706-15. PubMed ID: 10520713
    [No Abstract]   [Full Text] [Related]  

  • 3. False-positive positron emission tomographic scan for recurrent breast cancer resulting from a bee sting.
    Johnson DS; Wong JT; Coel MN
    Clin Nucl Med; 1999 Sep; 24(9):702-3. PubMed ID: 10478754
    [No Abstract]   [Full Text] [Related]  

  • 4. Imaging of breast cancer with [18F]fluorodeoxyglucose and positron emission tomography.
    Kubota K; Matsuzawa T; Amemiya A; Kondo M; Fujiwara T; Watanuki S; Ito M; Ido T
    J Comput Assist Tomogr; 1989; 13(6):1097-8. PubMed ID: 2584499
    [No Abstract]   [Full Text] [Related]  

  • 5. Diagnosis of recurrent and metastatic disease using f-18 fluorodeoxyglucose-positron emission tomography in breast cancer.
    Eubank WB
    Radiol Clin North Am; 2007 Jul; 45(4):659-67, vi. PubMed ID: 17706530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Positron emission tomography (PET) in diagnosis of breast carcinoma].
    Ivancevic V
    Zentralbl Chir; 1998; 123 Suppl 5():53-6. PubMed ID: 10063574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accuracy of whole-body fluorine-18-FDG PET for the detection of recurrent or metastatic breast carcinoma.
    Moon DH; Maddahi J; Silverman DH; Glaspy JA; Phelps ME; Hoh CK
    J Nucl Med; 1998 Mar; 39(3):431-5. PubMed ID: 9529287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular imaging in breast cancer.
    Schuster DM; Halkar RK
    Radiol Clin North Am; 2004 Sep; 42(5):885-908, vi-vii. PubMed ID: 15337423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Staging in patients with locoregionally recurrent breast cancer: current practice and prospects for positron emission tomography.
    van Oost FJ; van der Hoeven JJ; Hoekstra OS; Voogd AC; Coebergh JW; van de Poll-Franse LV
    Eur J Cancer; 2004 Jul; 40(10):1545-53. PubMed ID: 15196539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. F-18 FDG positron emission tomographic imaging in a case of ruptured breast implant: inflammation or recurrent tumor?
    Hurwitz R
    Clin Nucl Med; 2003 Sep; 28(9):755-6. PubMed ID: 12972998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The value of positron emission tomography in the follow-up for breast cancer.
    Siggelkow W; Zimny M; Faridi A; Petzold K; Buell U; Rath W
    Anticancer Res; 2003; 23(2C):1859-67. PubMed ID: 12820470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. F-18 fluorodeoxyglucose positron-emission tomography in the diagnosis of tumor recurrence and metastases in the follow-up of patients with breast carcinoma: a comparison to conventional imaging.
    Gallowitsch HJ; Kresnik E; Gasser J; Kumnig G; Igerc I; Mikosch P; Lind P
    Invest Radiol; 2003 May; 38(5):250-6. PubMed ID: 12750613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Value of combined FDG PET and MR imaging in the evaluation of suspected recurrent local-regional breast cancer: preliminary experience.
    Hathaway PB; Mankoff DA; Maravilla KR; Austin-Seymour MM; Ellis GK; Gralow JR; Cortese AA; Hayes CE; Moe RE
    Radiology; 1999 Mar; 210(3):807-14. PubMed ID: 10207485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FDG-PET and beyond: molecular breast cancer imaging.
    Quon A; Gambhir SS
    J Clin Oncol; 2005 Mar; 23(8):1664-73. PubMed ID: 15755974
    [No Abstract]   [Full Text] [Related]  

  • 15. Costosternal chondrodynia simulating recurrent breast cancer unveiled by FDG PET.
    Mathew AS; El-Haddad G; Lilien DL; Takalkar AM
    Clin Nucl Med; 2008 May; 33(5):330-2. PubMed ID: 18431146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. False-positive positron emission tomographic scan and computed tomography for recurrent vaginal cancer: pitfalls of modern imaging techniques.
    Tjalma WA; Carp L; De Beeck BO
    Gynecol Oncol; 2004 Feb; 92(2):726-8. PubMed ID: 14766276
    [No Abstract]   [Full Text] [Related]  

  • 17. Extracapsular breast implant rupture mimicking local cancer recurrence on
    Domínguez ML; Salvat C; F-Llana B; Vigil C; Suárez JP; González FM
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2018; 37(6):392-394. PubMed ID: 30031678
    [No Abstract]   [Full Text] [Related]  

  • 18. Early diagnosis of recurrent breast cancer with FDG-PET in patients with progressive elevation of serum tumor markers.
    Suárez M; Pérez-Castejón MJ; Jiménez A; Domper M; Ruiz G; Montz R; Carreras JL
    Q J Nucl Med; 2002 Jun; 46(2):113-21. PubMed ID: 12114874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of breast and gynecologic cancers by positron emission tomography.
    Dehdashti F; Siegel BA
    Semin Roentgenol; 2002 Apr; 37(2):151-68. PubMed ID: 12134368
    [No Abstract]   [Full Text] [Related]  

  • 20. Detection of locoregional and distant recurrences in breast cancer patients by using FDG PET.
    Eubank WB; Mankoff DA; Vesselle HJ; Eary JF; Schubert EK; Dunnwald LK; Lindsley SK; Gralow JR; Austin-Seymour MM; Ellis GK; Livingston RB
    Radiographics; 2002; 22(1):5-17. PubMed ID: 11796893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.